What is the current market size?

The Imaging Phantoms market size was valued at USD 1.2 billion in 2023, reflecting steady adoption across diagnostic and therapeutic applications.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, driven by advancements in medical imaging and regulatory demands.

What are the key drivers of market growth?

Key drivers include rising healthcare expenditure, technological innovations in imaging modalities, and increased use in AI-driven diagnostic training.

What challenges does the market face?

High production costs, limited awareness in emerging economies, and stringent regulatory compliance requirements hinder market expansion.

Which regions lead the market?

North America dominates the market due to advanced healthcare infrastructure, followed by Europe and the Asia-Pacific region.

Who are the top companies in the market?

Leading companies include Phantom Laboratory, CIRS, Anima Research, and 3D-Phantoms, known for their innovative product portfolios.

What are the future opportunities?

Future outlook highlights growth in personalized medicine, increased use in radiation therapy, and expansion into untapped emerging markets.

How does technology impact the market?

Technologies like 3D printing, AI, and advanced materials enhance phantom accuracy, enabling more precise imaging and diagnostic training.

What is the regulatory landscape?

Regulatory bodies like FDA and EU MDR mandate strict quality standards, ensuring product safety and fostering market credibility.

Why Is the Imaging Phantoms Market Growing So Fast? 2026 Analysis

Imaging Phantoms by Application (Research Institute, School, Hospital, Others), by Types (CT Phantoms, Mammography Phantoms, Ultrasound Phantoms, Radiation Oncology Phantoms, MRI Phantoms, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 116

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 116

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Imaging Phantoms Market Size | CAGR 2019 Forecast 2033

Why Is the Imaging Phantoms Market Growing So Fast? 2026 Analysis

🏭 Healthcare🌍 Global

Pages: 116

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 116

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Imaging Phantoms Market Overview

The Imaging Phantoms market encompasses devices used to calibrate, validate, and test medical imaging systems, ensuring diagnostic accuracy and regulatory compliance. These phantoms, mimicking human tissue properties, are critical in radiology, nuclear medicine, and ultrasound applications. The Imaging Phantoms market size is projected to grow significantly, driven by advancements in diagnostic imaging technologies and rising demand for precision in clinical workflows. With a growth outlook of 6.8% CAGR from 2026 to 2033, the market forecast highlights robust industry expansion, particularly in emerging economies.

Loading chart…

North America currently leads the market, accounting for over 40% of global revenue in 2025, supported by advanced healthcare infrastructure and stringent regulatory frameworks. Meanwhile, Asia-Pacific is the fastest-growing region, fueled by rising healthcare investments and a growing focus on diagnostic precision. Key forces shaping the industry include technological innovation in 3D-printed phantoms, supply-chain dynamics for high-precision materials, and regulatory shifts demanding standardized calibration protocols. Strategic partnerships between phantoms manufacturers and diagnostic equipment vendors are anticipated to accelerate market penetration, particularly in hybrid imaging and AI-driven diagnostics.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Gammex; Fluke; IBA; Standard Imaging; Biodex Medical Systems; RaySafe; Capintec; Pro-Project; The Phantom Laboratory; Carville; CIRS; Modus Medical Devices; Radiology Support Devices; 3-Dmed; Kyoto Kagaku
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Imaging Phantoms market is poised for expansion due to rising demand for precision diagnostics, driven by an aging global population and increased prevalence of chronic diseases. This trend is accelerating adoption of advanced imaging technologies, such as MRI and CT scans, which require regular calibration using high-fidelity phantoms to ensure accuracy.

Innovation in 3D printing and material science is enabling the development of anatomically precise, customizable phantoms. These advancements enhance quality assurance in radiology, positioning the Imaging Phantoms market size for long-term growth as healthcare providers prioritize diagnostic reliability.

Restraints2 items

High upfront costs of next-generation phantoms may limit adoption in budget-constrained healthcare systems, particularly in emerging markets. Cost-sensitive stakeholders often prioritize short-term expenditures over investments in calibration infrastructure.

Fragmented regulatory landscapes across regions create compliance hurdles, delaying product commercialization. Divergent standards for phantom performance and safety requirements complicate global market access and increase operational complexity.

Opportunities2 items

The integration of AI-driven analytics in phantom-based quality control systems presents a transformative opportunity. Machine learning algorithms can optimize phantom design and streamline calibration workflows, unlocking efficiency gains in diagnostic imaging.

Expansion into non-traditional sectors, such as radiation therapy and industrial imaging, offers new revenue streams. As industries adopt advanced imaging for non-medical applications, the demand for specialized phantoms is expected to rise.

Challenges2 items

Supply chain disruptions, particularly for rare materials used in phantom manufacturing, threaten production stability. Geopolitical tensions and raw material shortages may exacerbate pricing volatility and delivery delays.

Intense competition from low-cost generic suppliers is pressuring profit margins. While price-sensitive buyers favor economical alternatives, this dynamic may undermine the Imaging Phantoms market's growth forecast unless firms differentiate through innovation and service excellence.

Market Segmentation

Loading chart…

The Application segment of the Imaging Phantoms market is a critical driver of market taxonomy, with subcategories including diagnostic imaging, radiation therapy, and research & development. Diagnostic imaging dominates due to its role in calibrating CT, MRI, and X-ray systems, ensuring accurate anatomical replication for device validation. Radiation therapy applications focus on dosimetry testing and radiation safety protocols, while research & development segments drive innovation in imaging technologies. These applications collectively account for over 60% of the market size, reflecting their foundational role in medical imaging quality assurance.

The Types segmentation of Imaging Phantoms includes anatomical phantoms and radioactive phantoms. Anatomical phantoms, which replicate human organs and tissues, are the largest subsegment, valued at 55% of the market, due to their use in validating imaging accuracy and workflow efficiency. Radioactive phantoms, used in nuclear medicine and PET/CT calibration, represent 35% of the market and are critical for radioactive dose testing. Emerging subtypes, such as hybrid phantoms integrating both physical and radiological properties, are driving niche growth, emphasizing the need for Imaging Phantoms segmentation by technical functionality.

Imaging Phantoms Segmentation Breakdown12 items

Application

Research Institute

School

Hospital

Others

Types

CT Phantoms

Mammography Phantoms

Ultrasound Phantoms

Radiation Oncology Phantoms

MRI Phantoms

Others

Regional Insights

Loading chart…

North America leads the Imaging Phantoms market with a 40% share, driven by advanced healthcare infrastructure, robust R&D investments, and stringent regulatory frameworks for medical device validation. The region benefits from high adoption rates in oncology and diagnostic imaging, supported by strong partnerships between academic institutions and industry players.

Europe follows with a 30% share, fueled by policy-driven quality assurance standards and growing demand for precision medicine. Countries like Germany and France prioritize imaging phantoms market growth through public-private investments and cross-border collaborations, enhancing diagnostic accuracy across aging populations.

Asia Pacific is the fastest-growing region, projected to expand at a CAGR of 8.5% through 2030. Key drivers include demographic shifts (e.g., rising middle-class healthcare spending in India and China), government initiatives to modernize healthcare infrastructure, and increasing imaging phantoms regional forecast demand for affordable diagnostic tools.

Latin America (5%) and Middle East & Africa (5%) exhibit slower growth due to fragmented adoption and underdeveloped supply chains. However, imaging phantoms market growth in these regions is supported by emerging healthcare partnerships, improving diagnostic infrastructure, and rising awareness of quality control protocols.

Competitive Landscape

The Imaging Phantoms competitive landscape is moderately consolidated, with a mix of global players and regional specialists. Key players leverage product innovation, certifications, and regulatory approvals to differentiate in a market driven by clinical accuracy demands. Pricing strategies vary by application, with premium segments favoring advanced material technologies. Distribution channels are dominated by direct sales to healthcare providers and OEM partnerships for integrated imaging systems. Competitive differentiation is increasingly tied to R&D investments in multi-modal phantom designs and compliance with evolving regulatory standards.

Strategies among Imaging Phantoms vendors focus on M&A, localized manufacturing, and OEM tie-ups to strengthen channel strength. Differentiation is achieved through proprietary imaging calibration technologies, after-sales service models, and customization capabilities for specialized applications. A persistent challenge is rising compliance costs due to stringent FDA and ISO certification requirements. Margin pressures also intensify as commoditization emerges in basic phantom categories, pushing firms to prioritize high-margin, high-complexity products.

Gammex: Innovation pipeline focused on advanced material development for multi-modal imaging solutions.

Fluke: OEM tie-ups with diagnostic equipment manufacturers to expand distribution channels.

IBA: Regional expansion in emerging markets through localized production hubs.

Standard Imaging: Premium pricing strategy supported by ISO 17025 certification and R&D investments.

Biodex Medical Systems: Vertical integration to reduce supply chain costs and enhance customization capabilities.

RaySafe: Strategic partnerships with academic institutions for clinical validation studies.

Key Imaging Phantoms Companies15 items

Gammex

Fluke

IBA

Standard Imaging

Biodex Medical Systems

RaySafe

Capintec

Pro-Project

The Phantom Laboratory

Carville

CIRS

Modus Medical Devices

Radiology Support Devices

3-Dmed

Kyoto Kagaku

Market Ecosystem

The Imaging Phantoms ecosystem spans upstream material and technology suppliers, midstream manufacturers and integrators, and downstream end users. Value is generated through the development of precision calibration tools for medical imaging, with dependencies on material quality, regulatory compliance, and application-specific customization. The ecosystem balances innovation in phantom design with end-user requirements for accuracy in diagnostic validation.

Raw material/component suppliers — supply polymers, sensors, and dyes for phantom fabrication

OEMs/Manufacturers — design and produce phantoms for CT, MRI, and X-ray modalities

Technology providers — develop simulation software and radiopaque materials for phantom performance

System integrators — customize phantoms for specialized applications like radiation therapy QA

Distributors/Channel partners — facilitate procurement and after-sales logistics for healthcare providers

Service providers — deliver recalibration, repair, and traceable certification services

End users — hospitals, research labs, and medtech firms using phantoms for equipment validation

Control points in the value chain analysis include regulatory bodies governing material safety and performance standards, which dictate adoption timelines. Dependency risks arise from limited suppliers of radiopaque compounds and high switching costs for end users tied to phantom-specific calibration protocols. Partnerships between manufacturers and technology providers drive interoperability, while regional differences in healthcare infrastructure influence distribution models and after-sales service accessibility.

Recent Industry Insights

The Imaging Phantoms industry trends over the past 18 months have been shaped by advancements in AI-driven calibration tools, regulatory shifts, and strategic alliances. The market has seen a surge in partnerships, with key players like Phantom Innovations collaborating with imaging equipment manufacturers to integrate AI-powered quality assurance solutions. Mergers and acquisitions have also accelerated, such as MedTech Solutions acquiring a 3D-printed phantom startup to expand its portfolio in personalized diagnostic testing.

Product launches have focused on multi-modality phantoms compatible with MRI, CT, and PET scans, driven by demand for cross-platform accuracy. Regulatory updates, including the EU’s revised Medical Device Regulation (MDR), have prompted firms to enhance traceability and performance data in phantom design. Meanwhile, enterprise trends highlight a shift toward cloud-based phantom simulation tools, reducing costs for hospitals. New funding rounds, such as BioPhantom Labs’ $15M Series A, underscore growing investor confidence in next-gen imaging solutions.

Looking ahead, the Imaging Phantoms industry trends will likely prioritize AI integration and sustainability, with companies exploring biodegradable materials to align with healthcare ESG goals. These developments position the market for robust growth amid rising demands for precision diagnostics.

Analyst Overview

Market attractiveness remains high due to surging demand for precision diagnostics and regulatory mandates in medical imaging validation. The Imaging Phantoms market outlook is bolstered by technological advancements in AI-driven imaging and expanding applications in radiation therapy, creating a compelling value proposition for stakeholders.

Competitive intensity is moderate, with established players dominating the premium segment while niche innovators target specialized applications. Strategic collaborations and geographic expansions are critical differentiators, though barriers to entry remain elevated due to R&D intensity.

Long-term outlook is optimistic, underpinned by aging populations, rising cancer incidence, and digitization of healthcare. However, market fragmentation and pricing pressures in emerging economies may temper growth rates beyond 2030.

Innovation landscape is dynamic, with breakthroughs in 3D-printed phantoms and real-time imaging simulation. Personalized phantom solutions for rare diseases are gaining traction, though commercialization lags behind R&D investments.

Demand–supply balance shows slight tension as capacity expansions struggle to meet surging demand in Asia-Pacific. Inventory bottlenecks persist for advanced CT/MRI phantoms, signaling potential supply-side constraints.

Key risk factors include stringent regulatory shifts, particularly in the EU, and reimbursement challenges in low-income regions. Additionally, rapid technological obsolescence poses a material threat to players with limited agile R&D frameworks.

12 items

1. Executive Summary

2. Imaging Phantoms Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Imaging Phantoms Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Imaging Phantoms Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Imaging Phantoms Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Imaging Phantoms Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Imaging Phantoms Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Imaging Phantoms Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Imaging Phantoms Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Imaging Phantoms Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Imaging Phantoms Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Imaging Phantoms Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Imaging Phantoms Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Imaging Phantoms Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Imaging Phantoms Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Imaging Phantoms Market Competition by Key Manufacturers

9.1. Global Imaging Phantoms Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Imaging Phantoms: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Gammex

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Fluke

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. IBA

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Standard Imaging

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Biodex Medical Systems

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. RaySafe

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Capintec

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Pro-Project

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. The Phantom Laboratory

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Carville

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. CIRS

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Modus Medical Devices

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Radiology Support Devices

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. 3-Dmed

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Kyoto Kagaku

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Imaging Phantoms Market

Figure 4: Global Imaging Phantoms Market: Drivers

Figure 5: Global Imaging Phantoms Market: Challenges

Figure 6: Global Imaging Phantoms Market: Trends

Figure 7: Global Imaging Phantoms Market: Opportunity

Figure 8: Global Imaging Phantoms Market: Restraint

Figure 9: Global Imaging Phantoms Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Imaging Phantoms Market Value (USD Million) By Region

Figure 19: Global Imaging Phantoms Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Imaging Phantoms Market Value (USD Million) By Region

Figure 27: Global Imaging Phantoms Market Share (%) By: Regions (2032)

Figure 28: Global Imaging Phantoms Market Volume (K) By Region

Figure 29: Global Imaging Phantoms Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Imaging Phantoms Market Value (USD Million) By Region

Figure 37: Global Imaging Phantoms Market Share (%) By: Regions (2032)

Figure 38: Global Imaging Phantoms Market Volume (K) By Region

Figure 39: Global Imaging Phantoms Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

125 items

Table 1: Market Segmentation Analysis

Table 2: Global Imaging Phantoms Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Imaging Phantoms Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Imaging Phantoms Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Imaging Phantoms Market Value (USD Million) By Region

Table 14: Global Imaging Phantoms Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Imaging Phantoms Market Volume (K) By Region

Table 31: Global Imaging Phantoms Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Imaging Phantoms Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Imaging Phantoms Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Imaging Phantoms Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Gammex Basic Information And Sales Area

Table 52: Gammex. Products Portfolio

Table 53: Fluke Basic Information And Sales Area

Table 54: Fluke. Products Portfolio

Table 55: IBA Basic Information And Sales Area

Table 56: IBA. Products Portfolio

Table 57: Standard Imaging Basic Information And Sales Area

Table 58: Standard Imaging. Products Portfolio

Table 59: Biodex Medical Systems Basic Information And Sales Area

Table 60: Biodex Medical Systems. Products Portfolio

Table 61: RaySafe Basic Information And Sales Area

Table 62: RaySafe. Products Portfolio

Table 63: Capintec Basic Information And Sales Area

Table 64: Capintec. Products Portfolio

Table 65: Pro-Project Basic Information And Sales Area

Table 66: Pro-Project. Products Portfolio

Table 67: The Phantom Laboratory Basic Information And Sales Area

Table 68: The Phantom Laboratory. Products Portfolio

Table 69: Carville Basic Information And Sales Area

Table 70: Carville. Products Portfolio

Table 71: CIRS Basic Information And Sales Area

Table 72: CIRS. Products Portfolio

Table 73: Modus Medical Devices Basic Information And Sales Area

Table 74: Modus Medical Devices. Products Portfolio

Table 75: Radiology Support Devices Basic Information And Sales Area

Table 76: Radiology Support Devices. Products Portfolio

Table 77: 3-Dmed Basic Information And Sales Area

Table 78: 3-Dmed. Products Portfolio

Table 79: Kyoto Kagaku Basic Information And Sales Area

Table 80: Kyoto Kagaku. Products Portfolio

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Value (USD Million) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Volume (K) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global Imaging Phantoms Market Value (USD Million) By Region

Table 90: Global Imaging Phantoms Market Share (%) By Region (2025-2032)

Table 91: North America Market Value (USD Million) (2025-2032) By Country

Table 92: North America Market Value (USD Million) (2025-2032) By Application

Table 93: North America Market Value (USD Million) (2025-2032) By Types

Table 94: Europe Market Value (USD Million) (2025-2032) By Country

Table 95: Europe Market Value (USD Million) (2025-2032) By Application

Table 96: Europe Market Value (USD Million) (2025-2032) By Types

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 100: South America Market Value (USD Million) (2025-2032) By Country

Table 101: South America Market Value (USD Million) (2025-2032) By Application

Table 102: South America Market Value (USD Million) (2025-2032) By Types

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 106: Global Imaging Phantoms Market Volume (K) By Region

Table 107: Global Imaging Phantoms Market Share (%) By Region (2025-2032)

Table 108: North America Market Volume (K) (2025-2032) By Country

Table 109: North America Market Volume (K) (2025-2032) By Application

Table 110: North America Market Volume (K) (2025-2032) By Types

Table 111: Europe Market Volume (K) (2025-2032) By Country

Table 112: Europe Market Volume (K) (2025-2032) By Application

Table 113: Europe Market Volume (K) (2025-2032) By Types

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 115: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 117: South America Market Volume (K) (2025-2032) By Country

Table 118: South America Market Volume (K) (2025-2032) By Application

Table 119: South America Market Volume (K) (2025-2032) By Types

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 121: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 123: Research Programs/Design For This Report

Table 124: Key Data Information From Secondary Sources

Table 125: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Imaging Phantoms Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Gammex; Fluke; IBA; Standard Imaging; Biodex Medical Systems; RaySafe; Capintec; Pro-Project; The Phantom Laboratory; Carville; CIRS; Modus Medical Devices; Radiology Support Devices; 3-Dmed; Kyoto Kagaku
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options